Novartis Institutes For Bio Medical Research, Inc. Homology Medicines, Inc. (FIXX) insider trading activity

Novartis Institutes For Bio Medical Research, Inc. is > 10% Shareholder of Homology Medicines, Inc.. Currently has a direct ownership of 1.98 Million shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Apr 02, 2018, when has been sold 1,979,226 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.98M

0% 3M change

0% 12M change

Total Value Held $0

Novartis Institutes for BioMedical Research, Inc. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 02 2018	BUY Conversion of derivative security	-	1,979,226 Added 50.0%	1,979,226 Common Stock

Also insider at

NTLA

Intellia Therapeutics, Inc. Healthcare

> 10% Shareholder

SURF

Surface Oncology, Inc. Healthcare

> 10% Shareholder

NIf